搜索
Search
img

News Center

新闻中心

Kintor Pharma: Q1 2022 Business Update at A Glance

Kintor Pharma: Q1 2022 Business Update at A Glance

(Summary description)Q1 2022 Business Update at A Glance

  • Categories:Company news
  • Author:
  • Origin:
  • Time of issue:2022-04-19 09:37
  • Views:
Information

Previous: Kintor Pharma Announces First Patient Dosing in Multi-Regional Global Phase II Clinical Trial of ALK-1 Antibody and Nivolumab Combination Therapy for the Treatment of Advanced Hepatocellular Carcinoma
Next: Kintor Pharma’s Proxalutamide Demonstrated Reduction in Hospitalization/Mortality for Patients with Mild to Moderate COVID-19 in Phase III MRCT Study
Previous: Kintor Pharma Announces First Patient Dosing in Multi-Regional Global Phase II Clinical Trial of ALK-1 Antibody and Nivolumab Combination Therapy for the Treatment of Advanced Hepatocellular Carcinoma
Next: Kintor Pharma’s Proxalutamide Demonstrated Reduction in Hospitalization/Mortality for Patients with Mild to Moderate COVID-19 in Phase III MRCT Study

Related documents

MORE
There is currently no content to display
Please add data record on website background.

Copyright: Kintor Pharmaceutical Limited retains all copyrights.  苏ICP备19028699号-2  Powered by 300.cn

Complaints and Suggestions Tel: +86 512 62639935 Email: public@kintor.com.cn